Biopharma Week in Review - Vaccine Advisory Board Overhaul Sudden but Not Surprising

189 Views18 Jun 2025 11:38
Issuer-paid
Pharma benefited from some defensive sector rotation, led by the big obesity duo, LLY and NVO, ahead of this week’s major diabetes conference (ADA 2025).
What is covered in the Full Insight:
  • Pharma Sector Rotation
  • Vaccine Policy Overhaul
  • Drug Pricing and MFN Update
  • Key Company Developments
  • Market Reactions and Outlook
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 12-minute read)
Discussions
(Paid Plans Only)
chart-bar
  • Biopharma Week in Review - Vaccine Advisory Board Overhaul Sudden but Not Surprising
    18 Jun 2025
x